Literature DB >> 16106220

Accumulation of prion protein in the peripheral nervous system in human prion diseases.

Chin-Cheng M Lee1, Lu T Kuo, Chwan H Wang, Francesco Scaravilli, Shu F An.   

Abstract

After the finding that anti-prion antibodies stain sensory and sympathetic ganglia in variant Creutzfeldt-Jakob disease (vCJD), it was suggested that this localization supported the oral route of entry. However, prion accumulation subsequently also appeared in the peripheral nervous system (PNS) in sporadic cases. This study aims at evaluating the extent of prion protein accumulation in the PNS in all clinicopathologic subgroups of the disorder, with the exception of the familial and sporadic forms of fatal insomnia. Patients included 2 vCJD cases, 2 Gerstmann-Sträussler-Scheinker (GSS), 2 iatrogenic (iCJD), and 16 sporadic CJD (sCJD) cases. Gasserian (17) and spinal (9), celiac (2) and thoracic sympathetic (one) ganglia, spinal cord and medulla of one vCJD, 2 GSS, one iCJD, and 5 sCJD cases were examined. Immunostained sensory ganglia were seen in both vCJD, both iCJD, one GSS, and 10 sCJD cases; the celiac ganglion was positive in one of two sCJD cases, and the spinal dorsal horn and the medullary sensory nuclei were positive in one patient with vCJD, one with iCJD, and 3 with sCJD. Western blot demonstrated presence of PrP in the gasserian ganglion of one patient with sCJD. Accumulation of prion in ganglia (including autonomic) of the PNS, shared by all subgroups of spongiform encephalopathy, and in the dorsal horns and medullary sensory nuclei, shows that the sensory route is involved in the trafficking of this protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106220     DOI: 10.1097/01.jnen.0000175330.66715.08

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  6 in total

1.  Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease.

Authors:  Hélène Zéphir; Tanya Stojkovic; Jérome de Seze; Claude-Alain Maurage; Katell Peoc'h; Stéphane Haïk; Patrick Vermersch
Journal:  J Neurol       Date:  2009-02-07       Impact factor: 4.849

2.  Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c).

Authors:  Alessandro Didonna; Anja Colja Venturini; Katrina Hartman; Tanja Vranac; Vladka Čurin Šerbec; Giuseppe Legname
Journal:  PeerJ       Date:  2015-03-19       Impact factor: 2.984

3.  Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease.

Authors:  Peter Rudge; Zane Jaunmuktane; Harpreet Hyare; Matthew Ellis; Martin Koltzenburg; John Collinge; Sebastian Brandner; Simon Mead
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

4.  V180I genetic Creutzfeldt-Jakob disease with cardiac sympathetic nerve denervation masquerading as Parkinson's disease: A case report.

Authors:  Hiroaki Fujita; Keitaro Ogaki; Tomohiko Shiina; Hiroki Onuma; Hirotaka Sakuramoto; Katsuya Satoh; Keisuke Suzuki
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

5.  Prion type 2 selection in sporadic Creutzfeldt-Jakob disease affecting peripheral ganglia.

Authors:  Anna Hofmann; Arne Wrede; Wiebke M Jürgens-Wemheuer; Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol Commun       Date:  2021-11-24       Impact factor: 7.801

6.  Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.

Authors:  Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.